Novartis receives European Commission approval for Gilenya®, the first oral multiple sclerosis treatment
21 March 2011 | By Novartis
The European Commission has granted Novartis approval for Gilenya®...
List view / Grid view
21 March 2011 | By Novartis
The European Commission has granted Novartis approval for Gilenya®...
9 March 2011 | By Resolute Communications
XEPLION®, has received approval from the European Commission for the treatment of schizophrenia...
2 March 2011 | By Roche
Avastin in combination with paclitaxel will remain a treatment option for women with metastatic breast cancer in Europe...